- Advanced imaging and image-guided radiation therapy of head and neck malignancies
- Clinical trials of molecular targeted agents for head and neck cancer
- Radiation treatment planning and toxicity assessment
- Symptom assessment and supportive care
Support Care Cancer. 2018 Jul 16;:
Int J Radiat Oncol Biol Phys. 2018 Jul 15;101(4):763-764
Prevalence, prognosis, and treatment implications of retropharyngeal nodes in unknown primary head and neck carcinoma.
Oral Oncol. 2018 Jul;82:162-167
Development and validation of a radiomic signature to predict HPV (p16) status from standard CT imaging: a multicenter study.
Br J Radiol. 2018 Jun;91(1086):20170498
Partial Laryngeal IMRT for T2N0 Glottic Cancer: Impact of Image Guidance and Radiation Therapy Intensification.
Int J Radiat Oncol Biol Phys. 2018 Mar 30;:
Radiomic Biomarkers to Refine Risk Models for Distant Metastasis in HPV-related Oropharyngeal Carcinoma.
Int J Radiat Oncol Biol Phys. 2018 Feb 01;:
Delineation of the primary tumour Clinical Target Volumes (CTV-P) in laryngeal, hypopharyngeal, oropharyngeal and oral cavity squamous cell carcinoma: AIRO, CACA, DAHANCA, EORTC, GEORCC, GORTEC, HKNPCSG, HNCIG, IAG-KHT, LPRHHT, NCIC CTG, NCRI, NRG...
Radiother Oncol. 2017 Nov 24;:
The Current State of Biological and Clinical Implications of Human Papillomavirus-Related Oropharyngeal Cancer.
Semin Radiat Oncol. 2018 Jan;28(1):17-26
Association of Neurocognitive Deficits With Radiotherapy or Chemoradiotherapy for Patients With Head and Neck Cancer.
JAMA Otolaryngol Head Neck Surg. 2017 Nov 22;:
Cancer Clinical Research Unit (CCRU), Princess Margaret Cancer Centre
Assistant Professor, Departments of Radiation Oncology and Otolaryngology, University of Toronto
Head and Neck Site Group Leader, Radiation Medicine Program, University Health Network
Vice President, University Health Network Medical Staff Association